Our aim is to improve quality of life by means of tissue engineering and solve practical challenges of the related research in ethically sustainable methods.

Who we are

Scaffdex is family owned Finnish company established in Tampere in 2006. The first commercial products, CellCrown™ cell culture inserts, were developed with the researchers of Tampere University and launched in January 2007. In 2011 the first clinical tissue engineered application, RegJoint™ small joint implant, was launched. RegJoint™ is a local innovation, which is based on research and collaboration of Tampere University of Technology and Tampere University Hospital.

Scaffdex applies scientifically proven, innovative technologies and collaborates actively with universities.